Iridex (IRIX) Net Cash Flow (QoQ) (2011 - 2026)
Iridex (IRIX) Net Cash Flow (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Iridex | 13.32 Mn | 8.64 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -415.13% |
| Jan 3, 2026 | 137.84% |
| Sep 27, 2025 | -184.20% |
| Jun 28, 2025 | -108.69% |
| Mar 29, 2025 | 433.04% |
| Dec 28, 2024 | -483.67% |
| Sep 28, 2024 | 81.07% |
| Jun 29, 2024 | 19.69% |
| Mar 30, 2024 | -83.04% |
| Dec 30, 2023 | 52.22% |
| Sep 30, 2023 | -54.75% |
| Jul 1, 2023 | 57.18% |
| Apr 1, 2023 | -70.29% |
| Dec 31, 2022 | 23.57% |
| Oct 1, 2022 | 20.20% |
| Jul 2, 2022 | 16.19% |
| Apr 2, 2022 | -125.63% |
| Sep 26, 2020 | -23.69% |
| Jun 27, 2020 | 132.70% |
| Mar 28, 2020 | -485.77% |